Bipartisan Senate PBM Reform Bill Wouldn’t Ban Drug Rebates

By John Wilkerson / May 24, 2022 at 6:20 PM
A bipartisan Senate duo on Tuesday (May 24) introduced a bill that would ban spread pricing and pharmacy concessions, unless those concessions are shared with health plans, which they typically already are, and the bill would not ban drug rebates, thereby saving a huge offset for Democrats should they revisit budget reconciliation. The bill also would give the Federal Trade Commission the power to increase drug pricing transparency. Senate commerce committee Chair Maria Cantwell (D-WA) and Sen. Chuck Grassley (IA),...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.